Company Filing History:
Years Active: 2024-2025
Title: Innovations and Contributions of Qingbao Yang
Introduction
Qingbao Yang is a notable inventor based in Shandong, China. He has made significant contributions to the fields of biotechnology and molecular imaging. With a total of 3 patents to his name, his work has implications in medical applications and therapeutic developments.
Latest Patents
One of his latest patents is focused on an oligosaccharide, specifically a fucosylated chondroitin sulfate oligosaccharide. This invention includes a detailed preparation method that utilizes chondroitin sulfate A salt as a raw material. The process involves enzymolysis, group protection operations, and glycosylation to synthesize the oligosaccharide compound. The described structure allows for applications in the medical field, showcasing its potential benefits.
Another significant patent by Qingbao Yang is related to a dual-targeting compound and its preparation method. This invention pertains to nuclear medicine and molecular imaging, providing a dual-targeting compound that can be labeled with a radionuclide. The compound exhibits high affinity for both FAP and integrin αβ targets, enabling synergistic targeting in tumors. This innovation has promising applications in the diagnosis and therapy of diseases characterized by the overexpression of these targets.
Career Highlights
Qingbao Yang has worked with reputable companies such as Yantai Lannacheng Biotechnology Co., Ltd. and Yantai Dongcheng Biochemicals Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and innovation.
Collaborations
He has collaborated with notable individuals in his field, including Xiaoming Wu and Xiaoyuan Chen. These partnerships have likely enhanced his research and development efforts.
Conclusion
Qingbao Yang's contributions to biotechnology and molecular imaging through his patents demonstrate his innovative spirit and commitment to advancing medical science. His work continues to have a significant impact on the industry.